Aurinia Pharmaceuticals lifts 2.7%, 2 days' volume in a day January 09, 2019 17:00 EST
CANADIAN DAILY STOCK REPORT
Aurinia Pharmaceuticals Inc. (TSX:AUP), Canada's 2nd largest Biotechnology company by market cap, has lifted 25.0c (2.7%) from its last trading session of January 08 to close at CAD9.41. Compared with the S&P/TSX 60 Index which rose 11.5 points (1.3%) in the day, the relative price increase was 1.4%. The rise has been propped up by robust volume of 1.7 times the average daily volume of 44,836 shares. Its MCap is CAD802.9 million (US$606.7 million).